Oliver Sieber

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Dmitri Mouradov

Walter and Eliza Hall Institute

AUSTRALIA

View details

Kelly L. Rogers

Laboratory Head, Dynamic Imaging & Centre Manager

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

David Huang

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

YUMIKO HIROKAWA

University of Melbourne

AUSTRALIA

View details

Elizabeth Lieschke

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Delphine Merino

Laboratory Head

AUSTRALIA

View details

Sabrina Ghetti

Max Planck Institute of Molecular Physiology

GERMANY

View details

John Mariadason

La Trobe University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Sieber

Research Interests

Explore related searches

Contact this professor

Articles (10)

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

BCL-X<sub>L</sub> inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF<sup>V600E</sup> colorectal cancer

Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids

BCL-X<sub>L</sub> inhibitors enhance the apoptotic efficacy of BRAF inhibitors in <i>BRAF</i><SUP><i>V600E</i></SUP> colorectal cancer

Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells

Author Correction: DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis (Scientific Reports, (2018), 8, 1, (1767), 10.1038/s41598-018-20176-9)

Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer.

Unified framework for patient-derived, tumor- organoid-based predictive testing of standard-of- care therapies in metastatic colorectal cancer

<i>DUSP5</i> is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis (vol 8, 1767, 2018)

The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Feb,10.1038/s41418-023-01122-3, 2023)

Collaborators (8)

Dmitri Mouradov

Kelly L. Rogers

David Huang

YUMIKO HIROKAWA

Elizabeth Lieschke

Delphine Merino

Sabrina Ghetti

John Mariadason

Make your next move.